Tesla’s Robotaxi Launch, Chipotle’s Revenue Surge, and India’s Trade Success

Chipotle’s revenue grew 18% in Q2, driven by 11% same-store sales increase.
Tesla to unveil robotaxi service on October 10, aiming for high profitability.
India’s trade surplus with 151 countries in H1 2024, driven by strong exports.
The GUARD-AF trial showed increased AF detection with iRhythm’s Zio XT patch ECG.
Li Auto delivered 48,122 vehicles in August 2024, a 37.8% year-over-year increase.
Tech
E-commerce Competition
- Fee Waivers & Market Share: Chinese e-commerce giants like Pinduoduo, Alibaba, and Temu are offering significant fee waivers for merchants in a bid to gain market share. PDD Holdings, the parent company of Temu and Pinduoduo, announced a 10 billion yuan (US$1.4 billion) waiver over the next year. This fierce competition comes ahead of the implementation of China’s fair-competition regulations for the internet industry.
- Global Expansion & Competition: Temu’s global expansion faces fierce competition from rivals like Shein, Alibaba’s AliExpress, ByteDance’s TikTok Shop, and Amazon.com. Regulatory scrutiny around the world is another hurdle for these companies.
AI Integration & Decentralized Networks
- OKX Wallet & Nextme: OKX Wallet, a leading onchain wallet, has integrated with Nextme, a decentralized social economy network. This allows OKX Wallet users to access and interact with Nextme’s features like Farcaster and PayPal’s Venmo, but with enhanced encryption and true ownership of accounts, relationships, and data.
EV Growth & Autonomous Driving
- Li Auto’s Strong Performance: Li Auto, a leading Chinese electric vehicle manufacturer, delivered 48,122 vehicles in August, a 37.8% increase year-over-year. This brings the company’s total deliveries for 2024 to 288,103, and cumulative deliveries reach 921,467. Li Auto’s Li L6 model has gained popularity among young users, and its share of the RMB200,000 and higher NEV market grew to 18% in July.
- XPeng’s New Model: XPeng delivered 14,036 Smart EVs in August, a 3% year-over-year increase. The company launched its new compact sedan, Mona, aimed at middle and low-income buyers.
Nvidia’s AI Chip Dominance & Competition
- Market Share & Blackwell Platform: Nvidia dominates the AI chip market with an estimated market share of over 80%. The company’s GPUs are used in data centers for training machine learning models and running AI applications. Nvidia’s upcoming Blackwell platform, expected to launch in Q4 2025, promises 3 to 5 times more AI throughput than its Hopper platform.
- Custom AI Silicon: Companies like Amazon are developing custom AI silicon, like Trainium and Inferentia, to provide cost-efficient alternatives to Nvidia GPUs. While Nvidia dominates the market now, analysts predict it will lose market share as these alternatives become available.
AI Software & Investment Opportunities
- Revenue Potential: Cathie Wood, CEO of Ark Investment Management, predicts that AI software companies will generate $8 in revenue for every $1 spent on chips. This suggests significant growth potential for companies like Amazon, which is extensively using AI in its e-commerce, advertising, and cloud computing business. Amazon’s AWS is also developing its own data center chips and LLMs.
- Meta Platforms’ AI Focus: Meta Platforms uses AI to personalize content and increase user engagement on its platforms. It has developed its own open-source LLM, Llama. Both Amazon and Meta Platforms are considered attractively valued and could deliver significant returns if Wood’s prediction proves true.
Finance
Market Valuation Trends
- Top Performers: The combined market valuation of eight of the top-10 most valued firms surged by Rs 1,53,019.32 crore last week, driven by a record rally in equities. Bharti Airtel, Infosys, and Tata Consultancy Services led the gains, with Airtel’s valuation soaring Rs 47,194.86 crore to Rs 9,04,587.12 crore. Infosys added Rs 33,611.37 crore, reaching Rs 8,06,880.50 crore in valuation.
- Significant Gains: TCS saw its valuation jump Rs 31,784.9 crore to Rs 16,46,899.17 crore, while ICICI Bank’s valuation surged Rs 18,734.3 crore to Rs 8,66,374.41 crore. Reliance Industries’ market cap climbed Rs 13,396.42 crore to Rs 20,43,107.10 crore, and HDFC Bank’s valuation rallied Rs 5,600.24 crore to Rs 12,44,206.43 crore.
Chinese State Banks’ Profitability
- Margin Pressure: China’s largest state-owned banks are anticipated to face thinner margins later this year and into 2025. These banks recently reported profit declines, driven by Beijing’s efforts to support the troubled property sector and the overall economy.
- Mixed Performance: The Industrial and Commercial Bank of China, the world’s biggest bank by assets, reported a net profit of 170.5 billion yuan (US$24 billion) for the six months ended June 30, down 1.8 per cent year-on-year. The Agricultural Bank of China bucked the trend, posting a 2 per cent increase in net profit to 135.9 billion yuan. The Bank of China reported a net profit of 118.6 billion yuan, down 1.24 per cent year on year.
FPI Investment Activity
- Cautious Approach: Foreign investors took a cautious stance in August, investing Rs 7,320 crore in Indian equities. This cautiousness stems from high stock valuations and the unwinding of the Yen carry trade following the Bank of Japan’s interest rate hike.
- Shifting Focus: FPIs have been selling in the secondary market, where valuations are deemed high, and are redirecting their investments toward the primary market, which offers comparatively lower valuations. Notably, FPIs infused Rs 17,960 crore in the debt markets in August.
Indian Rupee Performance
- Depreciating Trend: The Indian rupee was the second-worst performing Asian currency in August after the Bangladeshi taka, due to strong dollar demand and outflows from domestic equities. It depreciated by 0.2 per cent during the month.
- Stability in FY24: Despite the recent depreciation, the rupee was the third most stable Asian currency against the US dollar in FY24, following the Hong Kong dollar and Singapore dollar. This stability was primarily attributed to the Reserve Bank of India’s timely interventions. Market participants expect the rupee to remain range-bound in the near term.
Healthcare
Cardiac Arrhythmia Screening
- GUARD-AF Trial Results: The GUARD-AF trial, conducted by Bristol-Myers Squibb-Pfizer Alliance, assessed the efficacy of screening for atrial fibrillation (AF) using iRhythm’s Zio XT patch ECG long-term continuous monitoring (LTCM) device in individuals aged 70 and older.
- Increased AF Detection: The trial indicated that Zio XT LTCM led to a significant increase in AF diagnosis compared to standard care (5.0% vs 3.3%).
- Stroke Prevention Evaluation: While the trial demonstrated increased AF detection, it did not reveal a significant difference in stroke hospitalization rates between the groups. However, event rates were low, and the trial was prematurely halted due to the COVID-19 pandemic.
- Future Implications: The trial suggests that screening for AF using LTCM could be beneficial for identifying undiagnosed AF in primary care settings. Upcoming trials will investigate the potential of LTCM in reducing the risk of heart failure and other cardiovascular complications associated with AF.
Hypertrophic Cardiomyopathy Treatment
- Aficamten Data Release: Cytokinetics, Incorporated (Nasdaq: CYTK) presented additional data from the SEQUOIA-HCM Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) at the European Society of Cardiology Congress 2024.
- Favorable Cardiac Remodeling: The trial data indicated that treatment with aficamten was associated with favorable cardiac remodeling, including reductions in left ventricular mass index, left ventricular maximal wall thickness, and left atrial volume index.
- Improved Symptoms & Function: Aficamten demonstrated improvements in echocardiographic measures of cardiac structure and function, without negatively impacting systolic function. It also significantly improved patient symptom burden and quality of life, as measured by the Kansas City Cardiomyopathy Questionnaire and the Seattle Angina Questionnaire.
- Biomarker Reduction: Treatment with aficamten resulted in a substantial reduction in NT-proBNP and hs-cTnI, cardiac biomarkers indicative of cardiac wall stress and myocardial injury, suggesting a potential for disease modification.
Ophthalmic Drug Development
- Chief Medical Officer Appointment: Belite Bio, Inc. (BLTE), a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeting degenerative retinal diseases, appointed Hendrik P. N. Scholl, MD, MA, as its Chief Medical Officer.
- Stargardt Disease Expertise: Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest natural history study of Stargardt disease.
- Tinlarebant Development: Dr. Scholl’s appointment further validates Belite Bio’s belief in the potential of Tinlarebant, its lead drug candidate, to improve the lives of patients living with Stargardt disease and dry AMD.
- Clinical Trials Progress: Belite Bio’s lead candidate, Tinlarebant, an oral therapy intended to reduce the accumulation of toxins in the eye, is currently being evaluated in Phase 3 studies (DRAGON and PHOENIX) in Stargardt and Geographic Atrophy patients.
Diabetes Management Growth
- Medtronic’s Diabetes Business: Medtronic (MDT), a medical device giant, reported continued growth in its diabetes business, which has become one of its most important segments in terms of revenue growth.
- MiniMed 780G Success: The MiniMed 780G, an automated insulin delivery (AID) system featuring advanced capabilities, has been a key driver of growth for Medtronic.
- CGM Partnership: Medtronic recently partnered with Abbott Laboratories to develop a continuous glucose monitoring (CGM) system compatible with its devices.
- Market Expansion: The diabetes market is expected to continue to grow as the global epidemic of diabetes worsens. Medtronic’s position in this market provides it with a significant long-term growth opportunity.
Robotic-Assisted Surgery Advancements
- Hugo System Development: Medtronic is continuing to test its robotic-assisted surgery (RAS) device, the Hugo system.
- Market Growth Potential: RAS represents a significant growth opportunity for Medtronic, with a vast runway for expansion.
- US Clearance Pending: The Hugo system is currently undergoing testing in the US, though it is already used in some countries abroad.
Economy & Real estate
Housing Market Shift
- City Center Surge: Homebuyers are returning to urban areas, reversing the pandemic-driven trend of suburban and rural migration. This shift is evident in cities like London, Singapore, and Hong Kong, where core areas are seeing stronger demand.
- Price Outperformance: Prime city markets are expected to outperform other areas in the coming years due to the attractiveness of employment opportunities and convenience.
- Regional Slowdown: As demand shifts back to cities, home sales in regional areas are expected to slow down, with price increases lagging behind those in capital cities.
- Luxury Segment Growth: In Singapore, the luxury property segment, including properties in the central business district, is expected to see improving sales due to the narrowing price gap between upscale and mid-tier properties.
Trade & Economic Outlook
- India’s Trade Surplus: India recorded a trade surplus with 151 countries in the first half of 2024, driven by strong exports. The US and Netherlands were the top surplus partners.
- Trade Deficit Concerns: India’s trade deficit with 75 countries, including China and Russia, was larger than its overall trade deficit, highlighting the need to reduce import dependence.
- China’s Dominance: China remains India’s largest trade deficit partner, accounting for 29.8% of India’s industrial goods imports. India aims to invest in domestic manufacturing to reduce reliance on imports from China.
- US as Top Trading Partner: The US has become India’s top merchandise trade partner, surpassing China in August 2024.
Public Sector Enterprise Performance
- Revised Guidelines: The Indian government is amending its 2016 guidelines for dividend payment, bonus issues, and share buyback by Central Public Sector Enterprises (CPSEs).
- Increased Market Capitalization: The combined market capitalization of CPSEs, banks, and insurance companies has significantly grown in recent years, indicating improved financial performance.
- Higher Dividends: The government aims to collect higher dividends from CPSEs, reflecting their strengthened financial position.
- Dividend Policy Reassessment: The government is reassessing its dividend policy for CPSEs, recognizing their improved financial performance and the need to encourage investor interest.
Real Estate Sales Momentum
- Strong Q1 Sales: India’s 21 major listed real estate developers reported a combined sale bookings of Rs 34,927.5 crore in the first quarter of FY24-25, driven by strong consumer demand for residential properties, particularly luxury homes.
- Godrej Properties Leads: Godrej Properties emerged as the largest listed player in the June quarter with pre-sales of Rs 8,637 crore.
- Revival Cycle: The post-pandemic rebound in the Indian real estate market, particularly in the housing segment, has benefitted branded and reputed developers, both listed and unlisted.
- Completed Projects: Homebuyers are opting for developers with a proven track record of completing projects, avoiding risks associated with delayed or stalled developments.
GST Revenue Trends
- August 2024 Collection: GST revenue collection for August 2024 stood at Rs 1,74,962 crore, marking a 10% increase compared to August 2023.
- Import Growth: The gross GST revenue from imports for August 2024 stood at Rs 49,976 crore, up by 12.1% compared to August 2023.
- State Performance: Maharashtra recorded the highest GST collections, registering a 13% increase compared to August 2023.
- Northeastern States: Some northeastern states, such as Arunachal Pradesh and Meghalaya, saw a decline in GST collections.
Retail
Fast Food Expansion
- Kiosk & Stall Growth: Restaurant chains like KFC, McDonald’s, and Haidilao are increasingly opening smaller kiosks and food stalls in high-traffic areas, such as subway stations, streets, and parks throughout China.
- Market Share Grab: This strategy aims to capitalize on the burgeoning fast-food market in China, which is projected to reach 4.28 trillion yuan (US$603 billion) by 2025.
- Cost Efficiency: Smaller stores are less expensive to build and operate, making them a cost-effective way to capture market share, particularly in lower-tier cities where demand for full-sized restaurants is lower.
- Value-for-Money Focus: The shift towards kiosks and stalls caters to consumers seeking budget-friendly options amidst slowing spending.
Restaurant Industry Outlook
- Temporary Headwinds: The Indian restaurant industry experienced challenges in the first quarter of the fiscal year due to high food inflation and a decline in “revenge eating” following the pandemic.
- Positive Expectations: Despite these obstacles, the industry is expected to recover due to strong fundamentals and declining food inflation.
- Profitable Growth: Restaurant chains are focusing on controlled, profitable expansion, targeting less saturated regions like South India.
- Consumer Spending Recovery: The restaurant industry’s recovery will depend on job creation and rising disposable incomes.
Multiplex Optimization & Expansion
- Screen Rationalization: Leading multiplex operator PVR INOX plans to close 70 non-performing screens in FY25 to improve profitability, despite adding 120 new screens.
- Capital-Light Growth: The company is transitioning to a capital-light growth model, reducing new screen investment and partnering with developers for a franchise-owned and company-operated (FOCO) model.
- Asset Monetization: PVR INOX is exploring the monetization of non-core real estate assets in prime locations to achieve a “net-debt free” status.
- South India Focus: The company aims to increase its presence in South India, which has high film demand but a relatively low number of multiplexes.
Retailer Challenges & Strategies
- Home Improvement Headwinds: Lowe’s, the second-largest home improvement retailer in the US, is navigating a challenging macroeconomic environment, with consumers hesitant to spend on major purchases due to inflation.
- Professional Focus: Lowe’s is aiming to capture market share in the commercial home improvement market, which accounts for approximately 25% of its sales.
- Capital Returns: Despite headwinds, Lowe’s remains a mature business with strong free cash flow, returning capital to shareholders through dividends and share buybacks.
- Long-Term Outlook: Lowe’s has a positive long-term outlook, driven by the increasing median age of US homes and a significant housing shortage.
Restaurant Bankruptcies
- Rising Bankruptcies: Restaurant bankruptcy filings have increased in 2024, driven by factors like declining consumer spending, rising labor costs, and the end of Covid-era government support.
- Notable Filings: At least 10 restaurant chains, including Roti Mediterranean, Buca di Beppo, World of Beer, Rubio’s, Melt Bar & Grilled, Kuma’s Corner, Red Lobster, Tijuana Flats, Sticky’s Finger Joint, and Boxer Ramen, have filed for bankruptcy in 2024.
- Challenges: These bankruptcies highlight the difficulties faced by restaurants in a challenging economic environment. Many attribute the challenges to high interest rates, inflation, and a slower return to pre-pandemic dining habits.
- Industry-Wide Trend: Restaurant bankruptcies are part of a broader trend of increasing corporate bankruptcies across various sectors.
Commodities
Oil and Gas Future
- Energy Transition: Investment in clean energy surpassed fossil fuel investment in 2023, reaching US$2 trillion. Despite this, wind and solar currently make up only 4% of global energy use, while electric vehicles account for 3% of vehicles worldwide.
- Fossil Fuel Reliance: While the IEA predicts a global surplus of fossil fuels in the coming decade, Opec and ExxonMobil maintain that oil and gas will remain vital, citing the need for reliable energy supplies and carbon capture technology.
- CCS Technology: The fossil fuel industry relies heavily on the development of carbon capture and storage (CCS) technology to reduce emissions. However, only 42 commercial CCS projects operate globally, capturing just 49 million tonnes of carbon annually, equivalent to 0.13% of global industry emissions.
- Net Zero Goals: The IEA estimates that 1 billion tonnes of carbon need to be captured annually by 2030 to achieve net zero targets. Current CCS capacity stands at only 20% of the capture target and 15% of the storage target, raising concerns about the viability of CCS technology.
Climate Change Negotiations
- Global Climate Goals: Governments have agreed on significant cuts to oil and gas production to achieve net zero targets, outlined in the 2015 Paris Agreement.
- Emission Reduction Targets: BP’s Energy Outlook suggests current trajectories fall short of the emissions reductions needed to meet net zero targets, potentially exhausting the remaining carbon budget for limiting global warming to 1.5 degrees by the 2040s.
- Industry Lobbying: The upcoming UN climate conference is expected to be contentious, with intense lobbying from Opec and oil companies seeking to protect future growth in the oil and gas sector.
- CCS Viability: The economic feasibility of CCS remains uncertain, with some projects facing abandonment due to cost concerns. The success of CCS technology is crucial for achieving the ambitious climate goals outlined in the Paris Agreement.
Politics & Legal
Class Action Lawsuits
- False and Misleading Statements: Bragar Eagel & Squire, P.C. filed class action lawsuits against several companies, alleging they made false and misleading statements about their financial performance and business operations, causing investor losses. These companies include Methode Electronics Inc. (MEI), DexCom, Inc. (DXCM), Endava PLC (DAVA), and Orthofix Medical Inc. (OFIX).
- Production Planning Deficiencies: The lawsuit against Methode Electronics claims that production planning deficiencies, inventory shortages, and vendor problems resulted from the company losing highly skilled employees during the COVID-19 pandemic.
- Reduced Revenue Guidance: The lawsuit against DexCom alleges that the company’s stock price declined after it announced a reduction in its revenue guidance for fiscal year 2024 due to “execution of several key strategic initiatives” not meeting expectations.
- Declining Demand for Services: The lawsuit against Endava alleges that the company made false statements about declining demand for services, delayed or canceled projects, and their impact on revenue and earnings.
Political News & Potential Policies
- Harris Leading Trump in Polls: Vice President Kamala Harris leads former President Donald Trump in eight recent polls, suggesting a potential shift in favor of the Democrats. Harris has gained support among women, Black, Hispanic, and younger voters.
- Universal Tariff Proposal: Trump proposed a universal tariff on all imported goods if re-elected, potentially impacting the $3 trillion worth of goods imported annually. This could fuel inflation and increase the cost of everyday goods.
- Chinese Goods Tariff: Trump also suggested a 60 percent tariff on all Chinese goods, adding to the 7.5 percent or 25 percent duties previously imposed on over $300 billion worth of Chinese goods.
- IEEPA for Economic Control: Trump could potentially utilize the International Emergency Economic Powers Act (IEEPA) to control economic transactions after an emergency declaration, allowing him to phase out imports of essential goods from China over four years.
Corporate Disputes & Cost Overruns
- CAE Inc. Lawsuit: Bleichmar Fonti & Auld LLP filed a class action lawsuit against CAE Inc., claiming that the company made false statements about significant cost overruns in its Defense and Security segment.
- Over $720 Million in Charges: The lawsuit alleges that CAE experienced significant cost overruns on fixed-price Defense contracts, leading to over $720 million in charges and profit adjustments.
- False Representations: The lawsuit further claims that CAE continued to make false representations about the strength of the Defense segment despite the cost overruns.
- Stock Price Decline: After multiple announcements about cost overruns and profit adjustments, CAE’s stock price declined significantly.
Copyright Disputes & Political Campaign Music
- ABBA Requests Trump to Stop Using Their Music: ABBA requested Donald Trump to stop playing their music at campaign rallies after learning about its unauthorized use through online videos.
- License Claims: Trump’s campaign asserted that they had secured a license to play ABBA’s music through agreements with BMI and ASCAP.
- Blanket License Implications: Despite artists’ objections, political campaigns do not require explicit permission to play songs at rallies if they have obtained a blanket license from ASCAP and BMI. This raises questions about the adequacy of current copyright laws in protecting artists’ rights.
- Growing Number of Artists Objecting: This incident adds to a growing list of artists who have objected to Trump using their music at campaign events without their consent.
Tax Law Loophole & Legislative Gridlock
- Tax Law Loophole Saving Corporations Millions: A loophole in the 2017 tax law allows large corporations to save millions of dollars that would have been paid to the government.
- Mismatched Effective Dates: The loophole resulted from mismatched effective dates for new tax rules in the 2017 tax law, which Congress failed to correct.
- IRS Attempts to Rectify, Tax Court Ruling: The IRS attempted to rectify the issue with regulations, but the U.S. Tax Court unanimously ruled that the law’s explicit language provides a double benefit to some companies.
- Cost of Legislative Gridlock: This case highlights the cost of legislative gridlock and the need for more careful drafting and review of tax laws to prevent unintended consequences.
Stock Picks
Restaurant
Chipotle’s Performance
- Revenue and Same-Store Sales Growth: Chipotle’s quarterly revenue for the period ending June 30 rose 18% to $3 billion, driven by a strong 11% increase in same-store sales.
- Transaction and Price Increases: Increased transactions contributed nearly 9% to the revenue growth, while higher prices added another 2%.
- Consistent Growth: Chipotle’s average growth rate over the past five years has been around 16%, with recent figures exceeding this figure.
- Leadership Transition: Chipotle’s CEO, Brian Niccol, departed for a position at Starbucks, with Scott Boatwright, the company’s Chief Operating Officer since 2017, assuming the role of interim CEO.
Valuation and Outlook
- High Valuation: Chipotle’s stock is currently trading at 50 times its estimated future earnings.
- Potential Correction: A correction in the stock price might be overdue due to its high premium.
- Long-Term Investment Potential: Despite the high valuation, Chipotle remains a good buy for long-term investors.
- Buying Opportunity: A further decline in price could present a buying opportunity for investors.
Electric Vehicles
Tesla’s RoboTaxi
- RoboTaxi Unveiling: Tesla is scheduled to unveil its robotaxi service on October 10.
- Profitability Potential: The robotaxi service is expected to be highly profitable for Tesla.
- Battery Production: Tesla’s battery production is rapidly increasing, supporting its energy storage business and potential supply for millions of electric cars.
- Ark Invest’s Projection: Ark Invest predicts that Tesla’s operating profit per kilowatt-hour deployed could be $466 for robotaxis, compared to $60 for normal electric cars.
Consumer Goods
Starbucks’ Turnaround
- Brand Recognition: Starbucks is ranked as the top restaurant brand globally by Brand Finance.
- Challenges: Starbucks has faced declining comparable sales due to sluggish consumer spending.
- New Leadership: Brian Niccol, former CEO of Chipotle, has joined Starbucks as CEO, bringing his proven track record of growth.
- Digital Ordering Enhancement: Niccol’s leadership is expected to enhance Starbucks’ digital ordering capabilities, improving efficiency and reducing wait times.
Small Cap Stocks
Small Cap Performance
- Historical Outperformance: Small-cap stocks have historically outperformed large-cap stocks during periods of declining interest rates.
- July Outperformance: Institutional investors sold shares of large-cap stocks and bought small-cap stocks in July, leading to the largest monthly outperformance of the S&P 600 relative to the S&P 500 since December 2000.
- Fed Rate Cuts: The anticipation of Federal Reserve rate cuts in September could further favor small caps.
- Valuation Gap: The significant valuation gap between small caps and large caps creates a potential opportunity for investors.
Miscellaneous
Lawsuits and Investigations
- Super Micro Computer Allegations: A complaint filed against Super Micro Computer accuses the company of misrepresenting its financial performance, relationships with related parties, and compliance with US export restrictions. The allegations stem from a short seller report by Hindenburg Research, which detailed concerns about Super Micro Computer’s transparency and potential violations of sanctions. Following the report, the company’s stock price dropped 21% on August 28, 2024, and it announced a delay in filing its Annual Report.
- Ford Motor Company Misrepresentations: A lawsuit against Ford alleges that the company misrepresented its warranty reserves and its ability to deliver higher quality at lower costs. Ford’s second-quarter 2024 financial results revealed a significant increase in warranty and recall costs, leading to an 18% decline in Ford’s stock price on July 25, 2024.
- Bolt Biotherapeutics Misleading Statements: A lawsuit alleges that Bolt Biotherapeutics misrepresented the effectiveness of its BDC-1001 cancer treatment and overstated the clinical and commercial prospects of its product pipeline. Following the revelation of these alleged misstatements, Bolt Biotherapeutics’ stock price declined. Investors who purchased Bolt securities between February 5, 2021, and May 14, 2024, have until September 3, 2024, to request to be appointed lead plaintiff in the class action lawsuit.
- Vicor Corporation Misleading Investors: A lawsuit against Vicor Corporation, a provider of power solutions, alleges that the company misled investors about securing a significant deal for its H100 product, which was believed to be with Nvidia Corporation. Vicor’s stock price fell after the company failed to discuss the deal in an earnings report and subsequently disclosed a sharp decline in new contracts and sales. Investors who purchased Vicor securities between April 23, 2023, and February 22, 2024, have until September 23, 2024, to request to be appointed lead plaintiff in the class action lawsuit.
- Ardelyx, Inc. Misleading Statements: A lawsuit alleges that Ardelyx, a pharmaceutical company, misled investors about its plans to include its drug XPHOZAH in the Therapeutic Drug Addendum Program (TDAPA). Ardelyx’s stock price dropped significantly after the company announced it would not pursue inclusion in TDAPA. Investors who purchased Ardelyx securities between October 31, 2023, and July 1, 2024, have until October 15, 2024, to request to be appointed lead plaintiff in the class action lawsuit.
- Outset Medical, Inc. Misrepresentations: A lawsuit claims that Outset Medical, a medical device company, misrepresented the marketing and regulatory status of its Tablo products and the company’s ability to ramp up sales. Outset Medical’s stock price declined following the revelation of these alleged misstatements. Investors who purchased Outset Medical securities between August 1, 2022, and August 7, 2024, have until October 28, 2024, to request to be appointed lead plaintiff in the class action lawsuit.
Market Performance and Trends
- NBCUniversal’s Olympic Success: The 2024 Paris Olympics drew over 30 million viewers across NBC’s TV and streaming platforms, generating a record $1.2 billion in advertising revenue. The streaming platform Peacock saw a surge in sign-ups during the Games, with an estimated 2.8 million new subscribers in the first week.
- Social Security Benefits: The average monthly Social Security benefit for those claiming at age 62 is $1,275, while those claiming at age 67 receive an average of $1,845, and those delaying to age 70 receive an average of $1,963.
- Li Auto’s Strong Sales: Li Auto, a Chinese electric vehicle manufacturer, delivered 48,122 vehicles in August 2024, a 37.8% year-over-year increase. As of August 31, 2024, Li Auto’s total deliveries for 2024 reached 288,103, and its cumulative deliveries reached 921,467.
- Slowdown in Indian Auto Industry: Sales of domestic passenger vehicles in India declined by 2-3% year-on-year in August, due to low demand and production cuts by automakers to manage high dealer inventories. Dealers are holding significant inventory, with the Federation of Automobile Dealers Associations (Fada) reporting 730,000 units, equivalent to over two months’ sales, while the Society of Indian Automobile Manufacturers (Siam) estimates the figure at 400,000 units.
